Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: BARD1 Gene Mutation|BRCA1 Gene Mutation|BRCA2 Gene Mutation|BRIP1 Gene Mutation|Estrogen Receptor Negative|HER2/Neu Negative|MLH1 Gene Mutation|MSH2 Gene Mutation|MSH6 Gene Mutation|PALB2 Gene Mutation|PMS2 Gene Mutation|Progesterone Receptor Negative|RAD51C Gene Mutation|RAD51D Gene Mutation|Triple-Negative Breast Carcinoma
Interventions: OTHER: Educational Intervention|OTHER: Genetic Counseling|OTHER: Genetic Counseling|OTHER: Laboratory Biomarker Analysis|OTHER: Questionnaire Administration
Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)